Drug companies have become frustrated with the newly revamped EudraVigilance database, which they claim is forcing them to waste time needlessly trawling through hundreds of individual case safety reports (ICSRs).
Since the updated database was launched last November, the number of ICSRs that companies are having to assess has increased substantially – by up to four times in some cases,...